KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Globus Medical (GMED) Restructuring Costs (2016 - 2025)

Historic Restructuring Costs for Globus Medical (GMED) over the last 13 years, with Q3 2025 value amounting to -$2.7 million.

  • Globus Medical's Restructuring Costs rose 2499.31% to -$2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.6 million, marking a year-over-year increase of 7281.26%. This contributed to the annual value of $29.6 million for FY2024, which is 5661.16% down from last year.
  • As of Q3 2025, Globus Medical's Restructuring Costs stood at -$2.7 million, which was up 2499.31% from $33.2 million recorded in Q2 2025.
  • Globus Medical's Restructuring Costs' 5-year high stood at $45.6 million during Q3 2023, with a 5-year trough of -$3.6 million in Q3 2024.
  • Over the past 5 years, Globus Medical's median Restructuring Costs value was $2.4 million (recorded in 2024), while the average stood at $7.9 million.
  • As far as peak fluctuations go, Globus Medical's Restructuring Costs crashed by 20776.86% in 2022, and later soared by 709769.94% in 2023.
  • Quarter analysis of 5 years shows Globus Medical's Restructuring Costs stood at $2.5 million in 2021, then skyrocketed by 46.06% to $3.6 million in 2022, then skyrocketed by 330.65% to $15.6 million in 2023, then increased by 9.67% to $17.1 million in 2024, then plummeted by 115.88% to -$2.7 million in 2025.
  • Its last three reported values are -$2.7 million in Q3 2025, $33.2 million for Q2 2025, and $1.1 million during Q1 2025.